ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial.

Thomas Sandmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.